Zobrazeno 1 - 10
of 827
pro vyhledávání: '"Thivolet, F."'
Autor:
Catinon, M., Cavalin, C., Chemarin, C., Rio, S., Roux, E., Pecquet, M., Blanchet, A. -S, Vuillermoz, S., Pison, C., Arbib, F., Bonneterre, V., dominique Valeyre, Freynet, O., Mornex, J. -F, Pacheco, Y., Freymond, N., Thivolet, F., Kambouchner, M., Bernaudin, J. -F, Nathalizio, A., Pradat, P., Rosental, P. -A, Vincent, M.
Publikováno v:
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases
Scopus-Elsevier
Scopus-Elsevier
Inhalation of mineral dust was suggested to contribute to sarcoidosis. We compared the mineral exposome of 20 sarcoidosis and 20 matched healthy subjects. Bronchoalveolar lavage (BAL) samples were treated by digestion-filtration and analyzed by trans
Autor:
Vincent, M., Perrin, G., Vuillermoz-Blas, S., Laennec, E., Blanchet, A.-S., Frecon, G., Thivolet, F., Roux, E., Chemarin, C.
Publikováno v:
In Revue de Pneumologie clinique 2011 67(5):298-303
Autor:
Mangiante L; Rare Cancers Genomics Team, Genomic Epidemiology Branch, International Agency for Research on Cancer/World Health Organization, Lyon, France.; Department of Medicine, Stanford University, Stanford, CA, USA., Alcala N; Rare Cancers Genomics Team, Genomic Epidemiology Branch, International Agency for Research on Cancer/World Health Organization, Lyon, France., Sexton-Oates A; Rare Cancers Genomics Team, Genomic Epidemiology Branch, International Agency for Research on Cancer/World Health Organization, Lyon, France., Di Genova A; Rare Cancers Genomics Team, Genomic Epidemiology Branch, International Agency for Research on Cancer/World Health Organization, Lyon, France.; Instituto de Ciencias de la Ingeniería, Universidad de O'Higgins, Rancagua, Chile.; Centro de Modelamiento Matemático UMI-CNRS 2807, Universidad de Chile, Santiago, Chile., Gonzalez-Perez A; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.; Centro de Investigación Biomédica en Red en Cáncer, Instituto de Salud Carlos III, Madrid, Spain., Khandekar A; Department of Cellular and Molecular Medicine, Department of Bioengineering and Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA., Bergstrom EN; Department of Cellular and Molecular Medicine, Department of Bioengineering and Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA., Kim J; Institute for Computational and Mathematical Engineering, Stanford University, Stanford, CA, USA.; Department of Computational Biology, Cornell University, Ithaca, NY, USA., Liu X; Institute for Computational and Mathematical Engineering, Stanford University, Stanford, CA, USA., Blazquez-Encinas R; Maimonides Biomedical Research Institute of Cordoba, Córdoba, Spain.; Department of Cell Biology, Physiology and Immunology, University of Cordoba, Córdoba, Spain.; Reina Sofia University Hospital, Córdoba, Spain.; CIBER Fisiopatología de la Obesidad y Nutrición, Córdoba, Spain., Giacobi C; Rare Cancers Genomics Team, Genomic Epidemiology Branch, International Agency for Research on Cancer/World Health Organization, Lyon, France., Le Stang N; UMR INSERM 1052, CNRS 5286, Cancer Research Center of Lyon, MESOPATH-MESOBANK, Department of Biopathology, Cancer Centre Léon Bérard, Lyon, France., Boyault S; Cancer Genomic Platform, Translational Research and Innovation Department, Centre Léon Bérard, Lyon, France., Cuenin C; EpiGenomics and Mechanisms Branch, International Agency for Research on Cancer/World Health Organization, Lyon, France., Tabone-Eglinger S; UMR INSERM 1052, CNRS 5286, Cancer Research Center of Lyon, MESOPATH-MESOBANK, Department of Biopathology, Cancer Centre Léon Bérard, Lyon, France., Damiola F; UMR INSERM 1052, CNRS 5286, Cancer Research Center of Lyon, MESOPATH-MESOBANK, Department of Biopathology, Cancer Centre Léon Bérard, Lyon, France., Voegele C; Rare Cancers Genomics Team, Genomic Epidemiology Branch, International Agency for Research on Cancer/World Health Organization, Lyon, France., Ardin M; Tumor Escape, Resistance and Immunity Department, Centre de Recherche en Cancérologie de Lyon, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Lyon, France., Michallet MC; Tumor Escape, Resistance and Immunity Department, Centre de Recherche en Cancérologie de Lyon, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Lyon, France., Soudade L; Rare Cancers Genomics Team, Genomic Epidemiology Branch, International Agency for Research on Cancer/World Health Organization, Lyon, France., Delhomme TM; Rare Cancers Genomics Team, Genomic Epidemiology Branch, International Agency for Research on Cancer/World Health Organization, Lyon, France.; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Poret A; Rare Cancers Genomics Team, Genomic Epidemiology Branch, International Agency for Research on Cancer/World Health Organization, Lyon, France., Brevet M; Cypath and Cypath-rb, Villeurbanne, France., Copin MC; University of Lille, Centre Hospitalier Universitaire Lille, Institut de Pathologie, Tumorothèque du Centre de Référence Régional en Cancérologie, Lille, France., Giusiano-Courcambeck S; Department of Pathology, Centre Hospitalier Universitaire Nord, Marseille, France., Damotte D; Centre de Recherche des Cordeliers, Inflammation, Complement and Cancer Team, Sorbonne Université, INSERM, Université de Paris, Paris, France.; Department of Pathology, Hôpitaux Universitaire Paris Centre, Tumorothèque/CRB Cancer, Cochin Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France., Girard C; Tumorothèque Centre Hospitalier Universitaire de Nantes, Nantes, France., Hofman V; Université Côte d'Azur, Laboratory of Clinical and Experimental Pathology, Nice Center Hospital, FHU OncoAge, Biobank BB-0033-00025 and IRCAN Inserm U1081/CNRS 7284, Nice, France., Hofman P; Université Côte d'Azur, Laboratory of Clinical and Experimental Pathology, Nice Center Hospital, FHU OncoAge, Biobank BB-0033-00025 and IRCAN Inserm U1081/CNRS 7284, Nice, France., Mouroux J; Université Côte d'Azur, Department of Thoracic Surgery, Nice Center Hospital, FHU OncoAge and IRCAN Inserm U1081/CNRS 7284, Nice, France., Cohen C; Department of Thoracic Surgery, FHU OncoAge, Nice Pasteur Hospital, Université Côte d'Azur, Nice, France., Lacomme S; Nancy Regional University Hospital, Centre Hospitalier Régional Universitaire, CRB BB-0033-00035, INSERM U1256, Nancy, France., Mazieres J; Toulouse University Hospital, Université Paul Sabatier, Toulouse, France., de Montpreville VT; Department of Pathology, Marie Lannelongue Hospital, Le Plessis Robinson, France., Perrin C; Hospices Civils de Lyon, Institut de Pathologie, Centre de Ressources Biologiques des HCL, Tissu-Tumorothèque Est, Lyon, France., Planchard G; Centre Hospitalier Universitaire de Caen, MESOPATH Regional Center, Caen, France., Rousseau N; Centre Hospitalier Universitaire de Caen, MESOPATH Regional Center, Caen, France., Rouquette I; Centre de Pathologie des Côteaux, Centre de Ressources Biologiques (CRB Cancer), IUCT Oncopole, Toulouse, France., Sagan C; Tumorothèque Centre Hospitalier Universitaire de Nantes, Nantes, France., Scherpereel A; University of Lille, Centre Hospitalier Universitaire Lille, INSERM, OncoThAI, NETMESO Network, Lille, France., Thivolet F; Hospices Civils de Lyon, Institut de Pathologie, Centre de Ressources Biologiques des HCL, Tissu-Tumorothèque Est, Lyon, France., Vignaud JM; Department of Biopathology, Centre Hospitalier Régional Universitaire de Nancy, Vandoeuvre-les-Nancy, France.; BRC, BB-0033-00035, Centre Hospitalier Régional Universitaire de Nancy, Vandoeuvre-les-Nancy, France., Jean D; Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, Functional Genomics of Solid Tumors, Paris, France., Ilg AGS; Direction Santé Environnement Travail, Santé Publique France, Paris, France., Olaso R; Université Paris-Saclay, CEA, Centre National de Recherche en Génomique Humaine, Evry, France., Meyer V; Université Paris-Saclay, CEA, Centre National de Recherche en Génomique Humaine, Evry, France., Boland-Auge A; Université Paris-Saclay, CEA, Centre National de Recherche en Génomique Humaine, Evry, France., Deleuze JF; Université Paris-Saclay, CEA, Centre National de Recherche en Génomique Humaine, Evry, France., Altmuller J; Cologne Centre for Genomics, Cologne, Germany., Nuernberg P; Cologne Centre for Genomics, Cologne, Germany., Ibáñez-Costa A; Maimonides Biomedical Research Institute of Cordoba, Córdoba, Spain.; Department of Cell Biology, Physiology and Immunology, University of Cordoba, Córdoba, Spain.; Reina Sofia University Hospital, Córdoba, Spain.; CIBER Fisiopatología de la Obesidad y Nutrición, Córdoba, Spain., Castaño JP; Maimonides Biomedical Research Institute of Cordoba, Córdoba, Spain.; Department of Cell Biology, Physiology and Immunology, University of Cordoba, Córdoba, Spain.; Reina Sofia University Hospital, Córdoba, Spain.; CIBER Fisiopatología de la Obesidad y Nutrición, Córdoba, Spain., Lantuejoul S; UMR INSERM 1052, CNRS 5286, Cancer Research Center of Lyon, MESOPATH-MESOBANK, Department of Biopathology, Cancer Centre Léon Bérard, Lyon, France.; Grenoble Alpes University, Saint-Martin-d'Hères, France., Ghantous A; EpiGenomics and Mechanisms Branch, International Agency for Research on Cancer/World Health Organization, Lyon, France., Maussion C; Owkin, New York, NY, USA., Courtiol P; Owkin, New York, NY, USA., Hernandez-Vargas H; UMR INSERM 1052, CNRS 5286, UCBL1, Centre Léon Bérard, Lyon, France.; Centre de Recherche en Cancérologie de Lyon, Lyon, France., Caux C; Tumor Escape, Resistance and Immunity Department, Centre de Recherche en Cancérologie de Lyon, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Lyon, France., Girard N; Institut Curie, Institut du Thorax Curie Montsouris, Paris, France.; Université de Versailles Saint-Quentin-en-Yvelines, Université Paris-Saclay, Versailles, France., Lopez-Bigas N; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.; Centro de Investigación Biomédica en Red en Cáncer, Instituto de Salud Carlos III, Madrid, Spain.; Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain., Alexandrov LB; Department of Cellular and Molecular Medicine, Department of Bioengineering and Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA., Galateau-Salle F; UMR INSERM 1052, CNRS 5286, Cancer Research Center of Lyon, MESOPATH-MESOBANK, Department of Biopathology, Cancer Centre Léon Bérard, Lyon, France., Foll M; Rare Cancers Genomics Team, Genomic Epidemiology Branch, International Agency for Research on Cancer/World Health Organization, Lyon, France. follm@iarc.who.int., Fernandez-Cuesta L; Rare Cancers Genomics Team, Genomic Epidemiology Branch, International Agency for Research on Cancer/World Health Organization, Lyon, France. fernandezcuestal@iarc.who.int.
Publikováno v:
Nature genetics [Nat Genet] 2023 Apr; Vol. 55 (4), pp. 607-618. Date of Electronic Publication: 2023 Mar 16.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Galateau Salle F; MESOPATH, MESONAT, MESOBANK Department of BioPathology Centre Leon Berard, Lyon, France. Electronic address: francoise.galateau@lyon.unicancer.fr., Le Stang N; MESOPATH, MESONAT, MESOBANK Department of BioPathology Centre Leon Berard, Lyon, France., Tirode F; University Claude Bernard Lyon, INSERM, CNRS, Research Cancer Center of Lyon, Centre Léon Bérard, Lyon, France., Courtiol P; OWKIN Paris, France., Nicholson AG; Department of Histopathology, Royal Brompton and Harefield NHS Foundation Trust and National Heart and Lung Institute, Imperial College, London, United Kingdom., Tsao MS; University Health Network, Princess Margaret Cancer Centre and University of Toronto, Department of Laboratory Medicine and Pathobiology, Toronto, Ontario, Canada., Tazelaar HD; Mayo Clinic, Scottsdale, Arizona., Churg A; Columbia University and Department of Pathology Vancouver, Canada., Dacic S; FISH and Developmental Laboratory at the University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania., Roggli V; Duke University Medical Center, Department of Pathology, Durham, North Carolina., Pissaloux D; Department of BioPathology-FISH Laboratory, Centre Leon Berard Lyon, France., Maussion C; OWKIN Paris, France., Moarii M; OWKIN Paris, France., Beasley MB; Mount-Sinai Medical Center, Department of Pathology, New York, New York., Begueret H; CHU Bordeaux, Haut Leveque Hospital, Department of Pathology, Bordeaux, France., Chapel DB; University of Chicago, Department of Pathology, Chicago, Illinois., Copin MC; University. Lille-CHU, Department of Pathology, Lille, France., Gibbs AR; University of Wales, Department of Cellular Pathology, Cardiff, United Kingdom., Klebe S; Department of Anatomical Pathology, Flinders University, Adelaide, Australia., Lantuejoul S; MESOPATH, MESONAT, MESOBANK Department of BioPathology Centre Leon Berard, Lyon, France., Nabeshima K; Department of Pathology, Fukuoka University School of Medicine and Hospital, Fukuoka, Japan., Vignaud JM; CHU Nancy, INSERM, University of Lorraine, Lorraine, France., Attanoos R; University of Wales, Department of Cellular Pathology, Cardiff, United Kingdom., Brcic L; Department of Pathology, Graz, Austria., Capron F; CHU Pitié Salpétrière Paris, Department of Pathology, Paris, France., Chirieac LR; Brigham and Women's Hospital, Boston, Massachusetts., Damiola F; MESOPATH, MESONAT, MESOBANK Department of BioPathology Centre Leon Berard, Lyon, France., Sequeiros R; MESOPATH, MESONAT, MESOBANK Department of BioPathology Centre Leon Berard, Lyon, France., Cazes A; MESOPATH, MESONAT, MESOBANK Department of BioPathology Centre Leon Berard, Lyon, France; CHU Bichat Department of Pathology, University Paris VII, Paris, France., Damotte D; MESOPATH, MESONAT, MESOBANK Department of BioPathology Centre Leon Berard, Lyon, France; CHU Cochin-Hotel Dieu, Department of Pathology, Paris, France., Foulet A; MESOPATH, MESONAT, MESOBANK Department of BioPathology Centre Leon Berard, Lyon, France; CH Le Mans, Department of Pathology, Pays de la Loire, France., Giusiano-Courcambeck S; MESOPATH, MESONAT, MESOBANK Department of BioPathology Centre Leon Berard, Lyon, France; CHU Hospital Nord, Marseille, University Aix-Marseille, Marseille, France., Hiroshima K; Tokyo Women's Medical University, Department of Pathology, Tokyo, Japan., Hofman V; MESOPATH, MESONAT, MESOBANK Department of BioPathology Centre Leon Berard, Lyon, France; Mayo Clinic, Scottsdale, Arizona; CHU Nice, Department of Clinical and Experimental Pathology (LPCE), Nice, France., Husain AN; University of Chicago, Department of Pathology, Chicago, Illinois., Kerr K; Aberdeen Royal Infirmary, Department of Pathology, Aberdeen, Scotland., Marchevsky A; Scotland Cedars-Sinai Medical Center, Department of Pathology, Los Angeles, California., Paindavoine S; University Claude Bernard Lyon, INSERM, CNRS, Research Cancer Center of Lyon, Centre Léon Bérard, Lyon, France., Picquenot JM; MESOPATH, MESONAT, MESOBANK Department of BioPathology Centre Leon Berard, Lyon, France; Department of Pathology, Henri Becquerel Centre, Rouen, France., Rouquette I; MESOPATH, MESONAT, MESOBANK Department of BioPathology Centre Leon Berard, Lyon, France; IUCT-Oncopôle, Department of Pathology, Toulouse, France., Sagan C; MESOPATH, MESONAT, MESOBANK Department of BioPathology Centre Leon Berard, Lyon, France; CHU Nantes, INSERM, Thorax Institute, Hôpital Laënnec CHU Nantes, Nantes, France., Sauter J; Memorial Sloan Kettering Cancer Center, Department of Pathology, New York, New York., Thivolet F; MESOPATH, MESONAT, MESOBANK Department of BioPathology Centre Leon Berard, Lyon, France; Hospices Civils, East Hospital Group, Department of Pathology, Lyon, France., Brevet M; MESOPATH, MESONAT, MESOBANK Department of BioPathology Centre Leon Berard, Lyon, France; Hospices Civils, East Hospital Group, Department of Pathology, Lyon, France., Rouvier P; CHU Pitié Salpétrière Paris, Department of Pathology, Paris, France., Travis WD; Memorial Sloan Kettering Cancer Center, Department of Pathology, New York, New York., Planchard G; MESOPATH, MESONAT, MESOBANK Department of BioPathology Centre Leon Berard, Lyon, France; Department of Pathology, CHU Caen, Caen, France., Weynand B; UZ Leuven, Department of Pathology, Leuven, Belgium., Clozel T; OWKIN Paris, France., Wainrib G; OWKIN Paris, France., Fernandez-Cuesta L; Genetic Cancer Susceptibility Group International Agency for Research on Cancer World Health Organization, Lyon, France., Pairon JC; INSERM, UPEC, Faculty of Medicine and CHI Creteil, Professional Pathologies and Environment Department, IST-PE, Creteil, France., Rusch V; Memorial Sloan Kettering Cancer Center, Department of Thoracic Surgery, New York, New York., Girard N; Department of Thoracic Oncology Institute Curie Paris, France and European Reference Network EURACAN, Centre Leon Berard, France.
Publikováno v:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2020 Jun; Vol. 15 (6), pp. 1037-1053. Date of Electronic Publication: 2020 Mar 09.
Autor:
Catinon, M., Busser, B., Thivolet, F., Kambouchner, M., Bernaudin, J.F., Freynet, O., Valeyre, D., Cavalin, C., Rosental, P.A., Sfarghiu, A.M., Arbib, F., Pison, C., Bonneterre, V., Motto-Ros, V., Vincent, M.
Publikováno v:
In Revue des Maladies Respiratoires January 2018 35 Supplement:A122-A122
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
European Respiratory Journal. 8:322-326
We report on two women presenting with cough and fever, 4 and 7 months, respectively, after starting breast radiation therapy following surgery for breast carcinoma. Chest roentgenogram and computed tomographic (CT) scan demonstrated alveolar opaciti
Autor:
Nistor, Claudiu1,2 (AUTHOR) anca-pati.cucu@drd.umfcd.ro, Carsote, Mara3,4 (AUTHOR) carsote_m@hotmail.com, Cucu, Anca-Pati2,5 (AUTHOR), Stanciu, Mihaela6 (AUTHOR) mihaela.stanciu@yahoo.com, Popa, Florina Ligia7 (AUTHOR) florina.popa@yahoo.com, Ciuche, Adrian1,2 (AUTHOR) adrian.ciuche@umfcd.ro, Ciobica, Mihai-Lucian8,9 (AUTHOR) lucian.ciobica@umfcd.ro
Publikováno v:
Diagnostics (2075-4418). May2024, Vol. 14 Issue 9, p919. 24p.
Autor:
Devouassoux, G., Cottin, V., Lioté, H., Marchand, Eric, Frachon, I., Schuller, A., Béjui-Thivolet, F., Cordier, J-F., Groupe d'Etudes et de Recherche sur les Maladies \\'Orphelines\\' Pulmonaires (GERM\\'O\\'P)
Publikováno v:
The European Respiratory Journal, Vol. 33, no. 5, p. 1053-1061 (2009)
European Respiratory Journal
European Respiratory Journal, European Respiratory Society, 2009, 33 (5), pp.1053-61. ⟨10.1183/09031936.00091608⟩
European Respiratory Journal
European Respiratory Journal, European Respiratory Society, 2009, 33 (5), pp.1053-61. ⟨10.1183/09031936.00091608⟩
International audience; The characteristics of patients with rheumatoid arthritis (RA) who develop obliterative bronchiolitis characterised by severe airflow obstruction have been hitherto poorly investigated. A retrospective study of 25 patients wit